ALBIO.PA PAR
Biosynex S.A.
1W: -3.4%
1M: +1.8%
3M: +0.9%
YTD: -13.7%
1Y: -23.9%
3Y: -89.9%
5Y: -93.9%
€0.89 ($0.99)
-0.01 (-1.11%)
Weekly Expected Move ±7.4%
€1
€1
€1
€1
€1
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
-$10M
-4.8% ▼
Capital Expenditures
$5M
+87.8% ▲
Free Cash Flow
-$15M
+69.6% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+100.0% ▲
Net Change in Cash
-$16M
+73.8% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $31M | $104M | $16M | -$37M | -$43M |
| Depreciation & Amort. | $7M | $2M | $21M | $13M | $21M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$7M | $578K | -$37M | $13M | $12M |
| Other Non-Cash Items | $695 | $3M | $5M | $3M | $565K |
| Operating Cash Flow | $32M | $110M | $5M | -$10M | -$10M |
| — Investing Activities — | |||||
| Capital Expenditures | -$9M | -$19M | -$30M | -$40M | -$5M |
| Acquisitions (Net) | $1M | $42K | $52K | -$16M | -$1M |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | -$10M | -$9M | $783K | $1M |
| Investing Cash Flow | -$8M | -$29M | -$39M | -$55M | -$5M |
| — Financing Activities — | |||||
| Net Debt Issuance | $6M | $17M | $12M | $8M | -$4M |
| Stock Repurchased | $0 | -$20M | -$2M | -$3M | $0 |
| Dividends Paid | $0 | -$2M | -$20M | $0 | $0 |
| Other Financing | $154K | $20M | -$728K | $808K | $3M |
| Financing Cash Flow | $11M | $14M | -$11M | $5M | -$801K |
| Net Change in Cash | $35M | $95M | -$45M | -$59M | -$16M |
| Cash End of Period | $37M | $132M | $87M | $20M | $5M |
| Free Cash Flow | $23M | $91M | -$25M | -$49M | -$15M |